pET-28a-hPKM1 Citations (6)
Originally described in: Pyruvate kinase M2 is a phosphotyrosine-binding protein.Christofk HR, Vander Heiden MG, Wu N, Asara JM, Cantley LC Nature. 2008 Mar 13;452(7184):181-6. doi: 10.1038/nature06667. PubMed Journal
Articles Citing pET-28a-hPKM1
| Articles |
|---|
| Pyruvate kinase isoenzyme M2 is a therapeutic target of gemcitabine-resistant pancreatic cancer cells. Kim DJ, Park YS, Kang MG, You YM, Jung Y, Koo H, Kim JA, Kim MJ, Hong SM, Lee KB, Jang JJ, Park KC, Yeom YI. Exp Cell Res. 2015 Aug 1;336(1):119-29. doi: 10.1016/j.yexcr.2015.05.017. Epub 2015 Jun 22. PubMed |
| PARP14 promotes the Warburg effect in hepatocellular carcinoma by inhibiting JNK1-dependent PKM2 phosphorylation and activation. Iansante V, Choy PM, Fung SW, Liu Y, Chai JG, Dyson J, Del Rio A, D'Santos C, Williams R, Chokshi S, Anders RA, Bubici C, Papa S. Nat Commun. 2015 Aug 10;6:7882. doi: 10.1038/ncomms8882. PubMed |
| Lapachol inhibits glycolysis in cancer cells by targeting pyruvate kinase M2. Shankar Babu M, Mahanta S, Lakhter AJ, Hato T, Paul S, Naidu SR. PLoS One. 2018 Feb 2;13(2):e0191419. doi: 10.1371/journal.pone.0191419. eCollection 2018. PubMed |
| CARM1 suppresses de novo serine synthesis by promoting PKM2 activity. Abeywardana T, Oh M, Jiang L, Yang Y, Kong M, Song J, Yang Y. J Biol Chem. 2018 Sep 28;293(39):15290-15303. doi: 10.1074/jbc.RA118.004512. Epub 2018 Aug 21. PubMed |
AAV-Txnip prolongs cone survival and vision in mouse models of retinitis pigmentosa.
Xue Y, Wang SK, Rana P, West ER, Hong CM, Feng H, Wu DM, Cepko CL.
Elife. 2021 Apr 13;10. pii: 66240. doi: 10.7554/eLife.66240.
PubMed
Associated Plasmids |
| Single-Cell FISH Analysis Reveals Distinct Shifts in PKM Isoform Populations during Drug Resistance Acquisition. Kim SH, Wi JH, Gwak H, Yang EG, Kim SY. Biomolecules. 2022 Aug 6;12(8):1082. doi: 10.3390/biom12081082. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.